MK-7 Vitamin K-2 Extra Strength - 300 mcg
Product analysis
MK-7 Vitamin K-2 Extra Strength - 300 mcg offers a focused vitamin K supplement with clear labeling and favorable value. It may support bone and mineral functions when intake is low, though findings for bone density and arterial flexibility are limited and mixed.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
Vitamin K is provided as MK-7, a favorably regarded form. Its form alone does not establish superior everyday health outcomes.
Ingredient Transparency100
The vitamin K amount and MK-7 form are clearly identified. That makes it straightforward to compare with other vitamin K supplements.
Value For Money100
The MK-7 serving is competitively priced. Its clear single-ingredient formula makes the value comparison straightforward.
Customer Satisfaction92
Customer feedback is very positive. Thousands of ratings provide a broad view of buyer satisfaction.
Product Focus78
A single active ingredient keeps the formula focused on vitamin K. Bone and arterial findings are limited and mixed, so wider health expectations should remain modest.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.33
- Also available
MK-7 Vitamin K-2 100 mcg$7.00- Customer rating
- 4.8 · 7,787 ratings
Goals
MK-7 Vitamin K-2 Extra Strength - 300 mcg targets bone-protein activation, with limited support for maintaining bone density in postmenopausal women. Its 300 mcg of identified MK-7 supports the activation of proteins involved in bone mineralization. The higher amount is not evidence of a larger bone benefit.
MK-7 Vitamin K-2 Extra Strength - 300 mcg has a narrow fit through limited support for arterial stiffness. Its 300 mcg vitamin K2 is explicitly identified as MenaQ7 MK-7, with no supported extra benefit from the higher amount.
MK-7 Vitamin K-2 Extra Strength - 300 mcg has a focused, narrow fit for arterial flexibility. The 300 mcg serving identifies MenaQ7, the preparation linked to selected arterial stiffness improvements in postmenopausal women. The higher amount does not imply a larger benefit.
MK-7 Vitamin K-2 Extra Strength - 300 mcg offers focused, limited support for arterial flexibility. Its 300 mcg of vitamin K2 is explicitly identified as MK-7, the form linked to selected arterial-stiffness improvements. The higher amount does not imply a larger benefit.
MK-7 Vitamin K-2 Extra Strength - 300 mcg offers focused nutritional support when dietary intake falls short. Vitamin K at 300 mcg contributes to normal bone and mineral metabolism.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin K2 (Menaquinone-7) | 300 mcg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
- Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
- Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
- Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
- Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
- Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
- Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
- Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
- Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
- Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
- Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
- The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
- Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
- Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
- The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
- Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
- Vitamin K status and cognitive function in healthy older adults.
- High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
- Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.